Albemarle Corporation(ALB)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Latest News & Analysis
Albemarle Executes Capital Discipline: Q3 Earnings Validate Restructuring Thesis
Q3 results validate Albemarle's capital discipline thesis, with cost reductions beating targets and positive free cash flow guidance.
Albemarle Strengthens the Core: Ketjen Sale Signals Capital Discipline and Strategic Focus
Albemarle's $660 million portfolio rationalization proves management conviction in lithium positioning, even as geopolitical tailwinds persist.
Albemarle Caught in Rare Earth Rally: Geopolitical Premium Meets Lithium Reality
Trump's tariff threats ignite a rare earth rally, sweeping Albemarle higher despite persistent lithium fundamentals challenges.
Albemarle's Q4 2024 Earnings: A Test of Resilience in a Volatile Lithium Market
Intraday update on ALB reveals significant cost cuts, revenue challenges, and strategic moves amid a volatile lithium market.
Albemarle Corporation Navigates Lithium Downturn: A Strategic Analysis
Albemarle faces lithium market headwinds, implementing strategic cost cuts amid fluctuating EV demand. Stay informed on ALB's strategies and market outlook.
Albemarle's Q4 2024 Earnings: Navigating Lithium Price Declines
Albemarle's Q4 2024 results reflect lithium price declines and EV market uncertainty. Cost-cutting and strategic adjustments aim to navigate challenges and secure long-term growth.